Ledger.Open graph →
SEC Form D · Amendment · filed July 31, 2020

Athenen Therapeutics, Inc

Offering
$15.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Andrew Levin · Boston, MADirectorSarah Reed · Boston, MAExecJames Schneider · Boston, MAExecSari Epstein · Boston, MAExecRavikiran Thummalapenta · CENTERVILLE, VADirectorTobias Peggs · Brooklyn, NYExecGeorge Matelich · Brooklyn, NYExecAdam Rosenberg · Lake Forest, CAExec · DirectorThomas D. Estes · Atlanta, GADirectorJohn Kim · Greenwich, CTExecJordan Noone · Calabasas, CAExecSari Epstein · Boston, MAExecAdam Rosenberg · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗